Related references
Note: Only part of the references are listed.Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells
Kyung-Jin Jung et al.
JOURNAL OF VIROLOGY (2008)
Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells
Tetsuya Usui et al.
RETROVIROLOGY (2008)
PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells
Soo-Jin Jeong et al.
VIROLOGY (2008)
Inhibition of methyltransferases results in induction of G(2)/M checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells
Arindam Dasgupta et al.
JOURNAL OF VIROLOGY (2008)
Shaping genetic alterations in human cancer: The p53 mutation paradigm
Thierry Soussi et al.
CANCER CELL (2007)
A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Δ12,14 prostaglandin J2 production
Hiroo Hasegawa et al.
BLOOD (2007)
Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation
Sanjeev Das et al.
CELL (2007)
Cellular senescence in cancer and aging
Manuel Collado et al.
CELL (2007)
TRAIL: a multifunctional cytokine
Uta Schaefer et al.
FRONTIERS IN BIOSCIENCE (2007)
P53 modulation of the DNA damage response
E. Scott Helton et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Coping with stress: multiple ways to activate p53
H. F. Horn et al.
ONCOGENE (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
MDM2 inhibitors for cancer therapy
Lyubomir T. Vassilev
TRENDS IN MOLECULAR MEDICINE (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
Ingo Ringshausen et al.
CANCER CELL (2006)
The regulation of INK4/ARF in cancer and aging
William Y. Kim et al.
CELL (2006)
Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma
Tom Van Maerken et al.
CANCER RESEARCH (2006)
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
Abh Datta et al.
BLOOD (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells
Llorenc Coll-Mulet et al.
BLOOD (2006)
Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence
Yu-Liang Kuo et al.
EMBO JOURNAL (2006)
Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma
M Tawara et al.
CANCER LETTERS (2006)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
C Tovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells
H Hasegawa et al.
BLOOD (2006)
Hzf, a p53-responsive gene, regulates maintenance of the G(2) phase checkpoint induced by DNA damage
M Sugimoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The P53 pathway: what questions remain to be explored?
A. J. Levine et al.
CELL DEATH AND DIFFERENTIATION (2006)
Dissecting p53-dependent apoptosis
J. E. Chipuk et al.
CELL DEATH AND DIFFERENTIATION (2006)
Divorcing ARF and p53: an unsettled case
Charles J. Sherr
NATURE REVIEWS CANCER (2006)
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
K Kojima et al.
BLOOD (2005)
Natural history of adult T-cell leukemia/lymphoma and approaches to therapy
GP Taylor et al.
ONCOGENE (2005)
Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis
M Yoshida
ONCOGENE (2005)
Molecular mechanisms of cellular transformation by HTLV-1 Tax
R Grassmann et al.
ONCOGENE (2005)
Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response
SJ Marriott et al.
ONCOGENE (2005)
Evidence for NF-κB- and CBP-independent repression of p53's transcriptional activity by human T-Cell leukemia virus type 1 tax in mouse embryo and primary human fibroblasts
A Miyazato et al.
JOURNAL OF VIROLOGY (2005)
The transcriptional targets of p53 in apoptosis control
J Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand
H Hasegawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Segregation of NF-κB activation through NEMO/IKKγ by Tax and TNFα:: implications for stimulus-specific interruption of oncogenic signaling
H Iha et al.
ONCOGENE (2003)
The current status of therapy for adult T-cell leukaemia-lymphoma in Japan
Y Yamada et al.
LEUKEMIA & LYMPHOMA (2003)
Share Paper
